Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by fredgoodwinsonon Aug 10, 2020 4:08am
295 Views
Post# 31386037

RE:RE:RE:RE:Who’s on the Board?

RE:RE:RE:RE:Who’s on the Board?

Two things really jarred in that last ann.

 

Re: the exclusions

 

‘this was an oversight on behalf of the Company’.

 

No it wasn’t - it was a culmination of the multiple errors of others apparently including an incorrectly drafted Clinical Protocol and chronic under-dosing of both drug and light leading to candidacy for exclusion.

 

‘The clinical protocol did not clearly define the bladder volume calculation to be used by the pharmacy’ - What??? - and this is the Company’s mistake??

 

It appears that Management is attempting to invoke vicarious liability (the responsibility of an employer for the negligent actions of their employee) but that is absolutely not the issue here. The harm is directly to the Company itself.

 

Acceptance of Shareholder liability for the mistakes of others represents a transfer of the cost of those mistakes from those who made them to the Company’s Shareholders. This may also have compromised our future rights under law.

 

No one wants to go to Court but this actually makes litigation more likely. By immediately and explicitly accepting total blame Management have removed any incentive for the Medical Establishment as eminently represented by our MSAB to repair the damage that a badly-drafted Clinical Protocol has imposed on our Company  - as could be achieved through a swift re-inclusion and treatment of those excluded . 

 

Management has for once moved with lightning speed - to totally own the negative consequences for its` Shareholders.

 
Bullboard Posts